Neurology / Major Depressive Disorder
Indication
Major Depressive Disorder
Assets addressing this indication.
Total attributable cost
$127.3B
$6,429/patient
Drug spend
Not yet sourced
All severities (2019 claims-based estimate) · US
Neurology / Major Depressive Disorder
Indication
Assets addressing this indication.
Total attributable cost
$127.3B
$6,429/patient
Drug spend
Not yet sourced
All severities (2019 claims-based estimate) · US
64 of 64 assets